Rifampin for Injection recall: Impurity Out of Spec
Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC…
Why was Rifampin for Injection recalled?
Failed Impurities/Degradation Specifications: High out of specification results obtained for related compound during stability testing.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: 7008990, exp. date Dec-2022; 7009025, exp. date Feb-2023; 7009085, 7009086, exp. date Apr-2023
- Product
- Rifampin for Injection, USP, 600 mg/vial, One Vial per carton, Rx only, Manufactured for: Mylan Institutional LLC, Morgantown, WV 26505 U.S.A., NDC…
- Recalling firm
- Mylan Pharmaceuticals Inc
- Quantity
- 33,893 vials
- Distribution
- Nationwide in the USA
- Recall date
- April 27, 2022
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)